Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Aclidinium Bromide : Clinical Benefit in Patients with Moderate to Severe COPD. / Ulrik, Charlotte Suppli.
I: The Open Respiratory Medicine Journal, Bind 6, 2012, s. 150-4.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Aclidinium Bromide
T2 - Clinical Benefit in Patients with Moderate to Severe COPD
AU - Ulrik, Charlotte Suppli
PY - 2012
Y1 - 2012
N2 - Long-acting bronchodilators are the mainstay of pharmacological treatment for patients with chronic obstructive pulmonary disease (COPD). The aim of this review is to provide an overview of the clinical studies evaluating the safety and efficacy of inhaled aclidinium bromide, a novel long-acting anticholinergic bronchodilator, for the treatment of COPD.
AB - Long-acting bronchodilators are the mainstay of pharmacological treatment for patients with chronic obstructive pulmonary disease (COPD). The aim of this review is to provide an overview of the clinical studies evaluating the safety and efficacy of inhaled aclidinium bromide, a novel long-acting anticholinergic bronchodilator, for the treatment of COPD.
U2 - 10.2174/1874306401206010150
DO - 10.2174/1874306401206010150
M3 - Journal article
C2 - 23264836
VL - 6
SP - 150
EP - 154
JO - The Open Respiratory Medicine Journal
JF - The Open Respiratory Medicine Journal
SN - 1874-3064
ER -
ID: 48598043